MyBlend, the Luxury Cosmetics Brand From the Clarins Group, is Making Progress, But Profitability Remains a Challenge

At the end of November, under a thick blanket of snow, the Bürgenstock welcomed a few members of the press to inaugurate the arrival of MyBlend at its Alpine Spa. Launched in 2007 within the Clarins group and entirely redesigned in 2022 by Doctor Olivier Courtin, the French personalized skincare brand is progressing cautiously in the vast luxury skincare market.

Traveling from Paris especially for the occasion, Olivier Courtin—founder of MyBlend, CEO of the Clarins group, and part of the second generation of owners alongside his brother Christian—spoke about the specific challenges of a growing “doctor brand.” Between an ultra-competitive market, major investments that slow down the path to profitability, and the need to build a name while maintaining a niche positioning, the right balance is still difficult to find.

Looking back a few years, Olivier Courtin envisioned, from his laboratory, a dermo-cosmetic range entirely customizable through the blending of ingredients—hence the name “MyBlend.” Observing the major impact of lifestyle on the skin, he imagined a beauty ritual surrounded by experts in dermatology, laser therapy, nutrition, and massage. A few years later, he kept the name but shifted the concept toward personalizing the routine rather than the product itself, expanding into beauty tech and micronutrition.

Today, the brand—supported by about thirty employees between Paris and its European markets—relies on a holistic approach to beauty inspired by Dr. Courtin’s research in longevity and epigenetics. The range, made up of 90% ingredients of natural origin, is built around three pillars: dermo-cosmetics, nutrition, and technology. While the brand’s flagship serum costs an average of €75 and the regenerative cream €260, the MyBlend LED mask—Courtin’s hallmark—sells for €1,250.

“It’s the technological tool that gets the strongest response among our customers, because it’s becoming democratized. I was the first to develop this mask with 288 pulsed red and infrared LEDs about ten years ago, but at the time the market wasn’t ready. Today, I am convinced that infrared is the future of skincare,” he says.

The most recent technological launch is the “Lifting Roller,” priced at €295, a tool combining microcurrent, vibration, and dual-headed mechanical massage. Used with a water-based serum to conduct the electric current, it promises to stimulate facial muscles, reactivate tissue regeneration, and redefine facial contours. Promising technologies indeed, but ones that—like the entire MyBlend range—struggle to stand out in an ultra-competitive market.

Positioning itself as a niche brand sold exclusively in exceptional locations, MyBlend has opted for controlled growth. It’s a long-term strategy fully embraced by Olivier Courtin: “I chose to develop brand awareness mainly through luxury hotels, then high-end perfumeries and pharmacies, and afterwards through e-commerce with our own website and partner platforms,” he explains. “I don’t want MyBlend to be too accessible. We are still a small player in the skincare universe, but it’s better to fight in a major market than dominate a nonexistent one,” he adds. Although the brand generated a little over €3 million in revenue in 2024—up around 40% year over year—MyBlend is still striving to reach profitability, facing massive investments in research and development. For now, this does not worry the founder: “I’m expecting an important year in 2026 in terms of figures. With brand awareness beginning to take hold, we are getting closer to our goal. We aim for profitability by 2030.”

The French brand is already present in some of the most prestigious establishments in Europe, such as the Mandarin Oriental Lutetia in Paris, the Hôtel du Golf Barrière in Deauville, the Triforet Alpine Resort in Austria, the Brach Madrid in Spain, and the St. Regis in Florence. The brand not only offers its products but also its facial and body treatment protocols, combining massages with cutting-edge technologies. It is therefore no coincidence that Courtin chose the Bürgenstock Resort Lake Lucerne to conquer the Swiss market. Spread over more than 10,000 square meters and recently awarded the “2025 Michelin Guide Wellness Award,” the Alpine Spa is considered one of the must-visit wellness destinations in the Alps. Working with only three carefully selected skincare brands, it offers MyBlend a major showcase.

Facing cosmetics giants, Olivier Courtin is driven by a single objective: “to become the most effective and avant-garde brand on the market.”

“When we talk about peptides and LED anti-aging masks, I want people to immediately think of MyBlend. Scientific evidence is, for me, the only way to compete with the giants of cosmetics,” he states. Some formulas and products, despite market popularity, were never launched because they did not deliver results that met the doctor’s standards. It is through scientific discoveries—used as a credibility marker—that Courtin plans to stand out. In this respect, peptides have proven effective. These small molecules made of amino acids help build skin proteins, support collagen synthesis, inhibit melanin, and improve elasticity and radiance. After years of research and several scientific publications in collaboration with Clarins laboratories and Professor Misery, MyBlend launched one of its signature products based on this molecule: the Peptides-complex 4P.

Another of Dr. Courtin’s convictions concerns epigenetics, a rapidly growing field of biology that studies how our environment influences gene expression—in other words, how our lifestyle affects the functioning and renewal of our cells.On this point, Courtin is unequivocal: “I have been working from the beginning on epigenetics and longevity, which I believe are the future of skincare. I am convinced that our lifestyle has a major impact on our skin. Long-term, I would like to create a unique place bringing together the elements of this concept to share good practices for healthy living and longevity.”

However, such projects will likely come later—just like the ambition to expand beyond Europe, particularly to the United States and China, or perhaps one day enter the haircare market. Those ideas are not excluded but are not current priorities. “For now, my ambition is not to broaden the range but to improve it—for example, by integrating UV filters into our creams or developing dietary supplements for the body. And above all, to increase brand awareness,” he concludes.

A significant challenge—one that will likely shape the future of MyBlend.